Loading...

iShares Genomics Immunology and Healthcare ETF

IDNAAMEX
Financial Services
Asset Management
$20.51
$0.06(0.29%)

iShares Genomics Immunology and Healthcare ETF (IDNA) Company Profile & Overview

Explore iShares Genomics Immunology and Healthcare ETF’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

iShares Genomics Immunology and Healthcare ETF (IDNA) Company Profile & Overview

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

SectorFinancial Services
IndustryAsset Management

Contact Information

DE

Company Facts

IPO DateJun 14, 2019
CountryUS
Actively Trading

Frequently Asked Questions

;